JP6816167B2 - 無煙タバコ中毒処置用のカンナビジオールおよびニコチンを含有する医薬製剤 - Google Patents

無煙タバコ中毒処置用のカンナビジオールおよびニコチンを含有する医薬製剤 Download PDF

Info

Publication number
JP6816167B2
JP6816167B2 JP2018558730A JP2018558730A JP6816167B2 JP 6816167 B2 JP6816167 B2 JP 6816167B2 JP 2018558730 A JP2018558730 A JP 2018558730A JP 2018558730 A JP2018558730 A JP 2018558730A JP 6816167 B2 JP6816167 B2 JP 6816167B2
Authority
JP
Japan
Prior art keywords
nicotine
cannabidiol
pharmaceutical composition
pharmaceutical
gum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2018558730A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019514990A (ja
JP2019514990A5 (enExample
Inventor
アール． ウィリアムズ，ジョニー
アール． ウィリアムズ，ジョニー
Original Assignee
シーブイ サイエンス，インク．
シーブイ サイエンス，インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シーブイ サイエンス，インク．, シーブイ サイエンス，インク． filed Critical シーブイ サイエンス，インク．
Publication of JP2019514990A publication Critical patent/JP2019514990A/ja
Publication of JP2019514990A5 publication Critical patent/JP2019514990A5/ja
Application granted granted Critical
Publication of JP6816167B2 publication Critical patent/JP6816167B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2018558730A 2016-05-16 2017-05-02 無煙タバコ中毒処置用のカンナビジオールおよびニコチンを含有する医薬製剤 Expired - Fee Related JP6816167B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662336990P 2016-05-16 2016-05-16
US62/336,990 2016-05-16
US15/426,617 2017-02-07
US15/426,617 US10653639B2 (en) 2016-05-16 2017-02-07 Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction
PCT/US2017/030558 WO2017200740A1 (en) 2016-05-16 2017-05-02 Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020213562A Division JP7216697B2 (ja) 2016-05-16 2020-12-23 無煙タバコ中毒処置用のカンナビジオールおよびニコチンを含有する医薬製剤

Publications (3)

Publication Number Publication Date
JP2019514990A JP2019514990A (ja) 2019-06-06
JP2019514990A5 JP2019514990A5 (enExample) 2020-06-18
JP6816167B2 true JP6816167B2 (ja) 2021-01-20

Family

ID=60297254

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018558730A Expired - Fee Related JP6816167B2 (ja) 2016-05-16 2017-05-02 無煙タバコ中毒処置用のカンナビジオールおよびニコチンを含有する医薬製剤
JP2020213562A Active JP7216697B2 (ja) 2016-05-16 2020-12-23 無煙タバコ中毒処置用のカンナビジオールおよびニコチンを含有する医薬製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020213562A Active JP7216697B2 (ja) 2016-05-16 2020-12-23 無煙タバコ中毒処置用のカンナビジオールおよびニコチンを含有する医薬製剤

Country Status (8)

Country Link
US (2) US10653639B2 (enExample)
EP (2) EP3936129A1 (enExample)
JP (2) JP6816167B2 (enExample)
CN (1) CN109152773A (enExample)
AU (2) AU2017267927B2 (enExample)
CA (1) CA3021835C (enExample)
ES (1) ES2898342T3 (enExample)
WO (1) WO2017200740A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2018504B1 (en) * 2017-03-13 2018-09-21 Pharma Unlimited B V Tobacco- and smoke-less products consumable by humans as epicurean or medical products and method of treating smoking addiction
US11166910B2 (en) * 2019-01-25 2021-11-09 Nordiccan A/S Cannabinoid chewing gum with sugar alcohols
US11253473B2 (en) * 2019-03-01 2022-02-22 Nordiccan A/S Method of producing tableted cannabinoid chewing gum
CN111789881A (zh) * 2019-04-04 2020-10-20 昆明医科大学 一种工业大麻提取物的用途
JP7736671B2 (ja) * 2019-08-30 2025-09-09 イーヴィー エスエー 充填顆粒、これらの製造方法及びこれらの使用
CN113100490A (zh) * 2021-05-21 2021-07-13 张家港外星人新材料科技有限公司 生物碱与酚反应合成物、雾化液、雾化弹及电子雾化器

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901248A (en) 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
CA2075517C (en) 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US20020098264A1 (en) 1998-11-27 2002-07-25 Cherukuri Subraman R. Medicated chewing gum delivery system for nicotine
FR2788982B1 (fr) * 1999-02-02 2002-08-02 Synthelabo Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
FI113340B (fi) 2002-02-20 2004-04-15 Tomi Jaervinen Uudet luonnon syklodekstriinin kompleksit
GB0712308D0 (en) 2007-06-25 2007-08-01 Kind Group Ltd An inhalable composition
GB2450753B (en) 2007-07-06 2012-07-18 Gw Pharma Ltd New Pharmaceutical formulation
EP2229158B1 (en) * 2007-12-20 2016-08-10 Fertin Pharma A/S Compressed chewing gum tablet
EP2280687B1 (en) 2008-03-26 2019-02-27 Stichting Sanammad Chewing gum compositions comprising cannabinoids
GB2464752B (en) * 2008-10-24 2010-09-08 Anna Louise Bullus Chewing gum composition
JP5675650B2 (ja) 2009-01-20 2015-02-25 ロサンゼルス バイオメディカル リサーチ インスティテュート アットハーバー− ユーシーエルエー メディカル センター 向精神薬の働きを向上させるソルビン酸、安息香酸及びその誘導体
CA2751627A1 (en) 2009-02-06 2010-08-12 Egalet Ltd. Pharmaceutical compositions resistant to abuse
EP2233134A1 (en) 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
US20100247586A1 (en) 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
WO2013001458A2 (en) * 2011-06-27 2013-01-03 Iq Tec Switzerland Gmbh Preforming pre-preg
US8623332B2 (en) 2011-07-06 2014-01-07 Fertin Pharma A/S Chewing gum having sustained release of nicotine
EP2793849A1 (en) 2011-12-22 2014-10-29 Fertin Pharma A/S Method of releasing nicotine from chewing gum
US20140166028A1 (en) 2012-12-14 2014-06-19 Richard C. Fuisz Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor or Smoke Producing Device Through Use of an Absorption Conditioning Unit
US10639439B2 (en) 2013-01-30 2020-05-05 Midwest Pharmaceuticals, Llc Smokeless THC and administration method thereof
EP4137142A1 (en) 2013-03-14 2023-02-22 Purple Mundo, Inc. Bioactive concentrates and uses thereof
US20150057342A1 (en) 2013-08-21 2015-02-26 Cannabics Pharmaceuticals Inc Compositions for combined immediate and sustained release of cannabinoids, methods of manufacture and use thereof
US9326967B2 (en) 2013-08-22 2016-05-03 Stephen C. Perry Vaporizable cannabinoid compositions
US10842786B2 (en) 2016-04-27 2020-11-24 Apirx Pharmaceutical Usa, Llc Chewing gum composition comprising cannabinoids and nicotine

Also Published As

Publication number Publication date
EP3458057A4 (en) 2020-02-05
CA3021835A1 (en) 2017-11-23
CA3021835C (en) 2022-03-22
JP2019514990A (ja) 2019-06-06
US20200230077A1 (en) 2020-07-23
CN109152773A (zh) 2019-01-04
JP2021059575A (ja) 2021-04-15
JP7216697B2 (ja) 2023-02-01
ES2898342T3 (es) 2022-03-07
AU2017267927A1 (en) 2018-11-08
AU2020256349B2 (en) 2022-03-31
EP3936129A1 (en) 2022-01-12
EP3458057B1 (en) 2021-09-08
AU2017267927B2 (en) 2020-07-30
AU2020256349A1 (en) 2020-11-12
WO2017200740A1 (en) 2017-11-23
EP3458057A1 (en) 2019-03-27
US11191736B2 (en) 2021-12-07
US10653639B2 (en) 2020-05-19
US20170326126A1 (en) 2017-11-16

Similar Documents

Publication Publication Date Title
JP7216697B2 (ja) 無煙タバコ中毒処置用のカンナビジオールおよびニコチンを含有する医薬製剤
US8858919B2 (en) Method of providing fast relief to a user of a nicotine chewing gum
JP6682450B2 (ja) 医療用チューインガム
US8828361B2 (en) Tobacco alkaloid releasing chewing gum
US9028803B2 (en) Chewing gum having sustained release of nicotine
US11191720B2 (en) Chewing gum with improved delivery of cannabinoids
US20200237658A1 (en) Cannabinoid chewing gum with improved release of cannabinoids
US20200237661A1 (en) Cannabinoid chewing gum with high intensity sweeteners
CA3031523A1 (en) Chewing gum with improved delivery of cannabinoids
US20200237660A1 (en) Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
AU2019425173B2 (en) Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
WO2020151793A1 (en) Chewing gum with improved delivery of cannabinoids
EP3930696A1 (en) Tableted chewing gum with enhanced delivery of cannabinoids

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200427

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200427

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20200427

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20200608

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200630

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200911

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20201124

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20201223

R150 Certificate of patent or registration of utility model

Ref document number: 6816167

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees